Overview of treatment-resistant depression

Area of Science:

• Psychiatry
• Clinical Psychology
• Pharmacology

Background:

• Major Depressive Disorder (MDD) patients often show inadequate response to antidepressant drugs.
• Treatment-Resistant Depression (TRD) describes this scenario, leading to diminished quality of life, functional impairment, and increased healthcare costs.
• A lack of consensus on TRD definition hinders treatment efficacy comparisons and guideline development.

Purpose of the Study:

• To review common issues concerning TRD, including definitions of adequate antidepressant trials and TRD.
• To summarize the prevalence, clinical outcomes, and proposed staging models for TRD.
• To highlight variations in TRD definitions within depression treatment guidelines and review current treatment options.

Main Methods:

• Literature review of definitions, prevalence, clinical outcomes, and staging models for TRD.
• Analysis of treatment guidelines for depression, focusing on TRD definitions.
• Comprehensive review of current and experimental treatment options for TRD.

Main Results:

• TRD is associated with significant decrements in mental and physical health-related quality of life, functional impairment, and productivity loss.
• Inconsistent definitions of TRD across studies complicate interpretation of treatment efficacy.
• Existing treatment guidelines for depression lack specific TRD protocols due to definitional ambiguity.

Conclusions:

• Establishing a consensus definition for TRD is crucial for advancing research and clinical practice.
• Standardized diagnostic criteria and specific treatment guidelines are needed for effective TRD management.
• A wide array of treatment options, from pharmacotherapy to neurostimulation and novel agents, are available for TRD.